Healthcare Realty Trust Reports Results for the First Quarter

Rhea-AI Summary

Healthcare Realty Trust Incorporated (NYSE:HR) reported a (loss) income of $(310.8) million for the first quarter of 2024. Normalized FFO per share was $0.39. The Company announced a $383 million JV with KKR at a 6.6% cap rate and expects more than $300 million in proceeds from additional transactions. They repurchased 3.0 million shares worth $41.7 million in April.

Positive

• Strong new leasing momentum with leases totaling approximately 440,000 square feet

• Increased tenant retention to 84.8% from 78.2% in the fourth quarter of 2023

• Multi-tenant sequential occupancy gains in-line with expectations, with absorption of 56,972 square feet

Negative

• Net (loss) income of $(310.8) million for the first quarter of 2024

• Reduction in credit spread by only 1 basis point in March 2024

• Forecasted earnings per share from $(0.11) to $(1.30) for the second quarter of 2024

Insights

Financial Analyst

Reviewing the Q1 financial results from Healthcare Realty Trust, particularly the net loss of $310.8 million and the normalized FFO per share of $0.39, it's clear that investors need to look beyond the headline net loss figure. The loss seems primarily driven by non-cash goodwill and real estate impairments. The normalized FFO, which adjusts for certain items, is more indicative of the company's operating performance. The debt levels are at the upper end of the company's target range and the 6.5 times net debt to adjusted EBITDA ratio indicates a relatively leveraged position, although within management's comfort zone. The share repurchase program, backed by the board's authorization of up to $500 million, signals confidence from the leadership in the intrinsic value of the company's shares. Investors should balance the negative net loss with the company's strategic joint venture with KKR and additional transactions expected to generate significant proceeds. These activities could provide liquidity and fuel future growth or further share repurchases.

Real Estate Market Analyst

Focusing on the real estate market specifics, the announced joint venture with KKR is a strategic move that allows diversification and expansion of Healthcare Realty Trust's investment scope into high-quality stabilized medical office buildings (MOBs). The cap rate of 6.6 on the contributed properties is a important metric that lies at the core of real estate investment trusts' valuation. It represents the expected yield on an investment property and is within the typical range for medical properties, reflecting a balance between risk and return. The increase in tenant retention to 84.8 from 78.2 suggests improving tenant stability, which can be seen as a positive sign for investors looking for predictable revenue streams. Meanwhile, the strong leasing activity, with new leases totaling approximately 440,000 square feet, should be considered a positive sign of operational momentum and market demand for the company's properties.

Dividend Analyst

From a dividend perspective, the focus of Healthcare Realty Trust on improving its dividend coverage is important for income-focused investors. The consistent dividend payment at $0.31 per share, despite the reported net loss, indicates the company's commitment to returning value to shareholders. Investors should note that maintaining this dividend level requires the trust to generate sufficient operational cash flow to cover the payout, which is where the normalized FFO becomes a relevant metric. The improvement in operational performance, if sustainable, could strengthen dividend coverage over time. However, investors must keep an eye on the payout ratio and the company's efforts to manage its debt levels, as these factors are directly linked to the sustainability of the dividend payments.

The Company is focused on its top priorities of capital allocation and operational momentum to accelerate FFO growth and improve dividend coverage.

CAPITAL ALLOCATION MOMENTUM

• Announced a $383 million JV with KKR at a 6.6% cap rate with expected proceeds of $300 million
• Expects additional proceeds of more than $300 million within 90 days from separate transactions
• Repurchased 3.0 million shares totaling $41.7 million in April

OPERATIONAL MOMENTUM

• Delivered multi-tenant absorption of 57,000 square feet, or 17 basis points, on pace with expectations
• Generated strong new leasing momentum with new leases of approximately 440,000 square feet
• Improved tenant retention to 84.8%, up from 78.2% in fourth quarter 2023

NASHVILLE, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the first quarter ended March 31, 2024. Net (loss) income attributable to common stockholders for the three months ended March 31, 2024 was $(310.8) million, or $(0.82) per diluted common share. Normalized FFO per share totaled $0.39 for the three months ended March 31, 2024.

CAPITAL ALLOCATION

• The Company announced a strategic JV with KKR & Co., Inc. with the following key terms:
  • The Company will contribute 12 existing properties at a value of $382.5 million, representing a cap rate of approximately 6.6%.
  • KKR will make an initial capital contribution into the JV equal to 80% of the value of the properties.
  • The Company will retain a 20% interest and will manage the JV, as well as continue to oversee day-to-day operations and leasing of the properties.
  • The JV is expected to generate approximately $300 million of proceeds to the Company, and the contribution of the properties is expected to occur throughout May and June, subject to customary closing conditions.
  • Asset-level financing is not expected to be used for the initial JV seed portfolio or future investments.
  • KKR has also committed up to $600 million of additional equity capital to invest in high-quality stabilized MOBs, which may include additional contributions of the Company's properties.
• The Company has additional transactions under contract and letters of intent that are expected to generate further proceeds of more than $300 million within 90 days.
• The impact of additional transactions as well as the KKR JV will be incorporated into the Company's guidance expectations when they are completed.
• Proceeds are expected to be used to repurchase shares on a leverage neutral basis, maintaining debt to adjusted EBITDA between 6.0 and 6.5 times.
• In April, the Company repurchased 3.0 million shares totaling $41.7 million at an average price of $14.07 per share.
• The Company's Board of Directors has authorized the repurchase of up to $500.0 million of outstanding shares of the Company’s common stock.

MULTI-TENANT OCCUPANCY AND ABSORPTION

• Multi-tenant sequential occupancy gains were in-line with expectations provided in the February 2024 Investor Presentation as shown below:
  

		1Q 2024 ACTUAL
	Absorption (SF)	56,972
	Change in occupancy (bps)	+ 17

• Strong multi-tenant absorption was noteworthy given the 1,603,000 square feet of expirations in first quarter, nearly double the expirations in the fourth quarter 2023 and the highest quarterly level scheduled in 2024.
• The multi-tenant portfolio leased percentage was 87.1% at March 31, which was 170 basis points greater than occupancy of 85.4%.
• Multi-tenant occupancy has increased by 70 basis points since third quarter of 2023. For the Legacy HTA properties, multi-tenant occupancy has increased by 130 basis points for the same period.
• The multi-tenant occupancy and NOI bridge can be found on page 5 of the Key Highlights Investor Presentation.

LEASING

• Portfolio leasing activity that commenced in the first quarter totaled 2,077,000 square feet related to 411 leases:
  • 1,595,000 square feet of renewals
  • 482,000 square feet of new and expansion lease commencements

• The Company signed new leases totaling approximately 440,000 square feet in the quarter.

SAME STORE

• Same Store cash NOI for the first quarter increased 3.0% over the same quarter in the prior year, up from 2.7% year over year growth in fourth quarter 2023.
• Tenant retention for the first quarter was 84.8%, an increase from 78.2% in fourth quarter 2023.
• Operating expense growth was 1.7% over the same quarter in the prior year, down from 4.1% year over year growth in fourth quarter 2023.
• First quarter predictive growth measures in the Same Store portfolio include:
  • Average in-place rent increases of 2.8%
  • Future annual contractual increases of 2.9% for leases commencing in the quarter.
  • Weighted average MOB cash leasing spreads of 3.7% on 1,313,000 square feet renewed:
    • 4% (<0% spread)
    • 10% (0-3%)
    • 54% (3-4%)
    • 31% (>4%)

BALANCE SHEET

• Net debt to adjusted EBITDA was 6.5 times at March 31, 2024.
• In March 2024, the Company reduced its credit spread on its term loans and credit facility by 1 basis point as a result of meeting certain sustainability targets.
• As of March 31, 2024, variable rate debt was 10% of outstanding, an improvement from 16% as of March 31, 2023.

DIVIDEND

• The Company is focused on its top priorities of capital allocation and operational momentum to accelerate earnings growth and improve dividend coverage.
• A dividend of $0.31 per share was paid in March 2024. A dividend of $0.31 per share will be paid on May 23, 2024 to stockholders and OP unitholders of record on May 13, 2024.

GUIDANCE

• The Company affirms its 2024 Normalized FFO per share guidance as shown below:
  

		ACTUAL				EXPECTED 2Q 2024							EXPECTED 2024
		1Q 2024				LOW			HIGH				LOW			HIGH
	Earnings per share	$(0.82)				$(0.12)			$(0.11)				$(1.30)			$(0.80)
	NAREIT FFO per share	$(0.30)				$0.35			$0.36				$0.77			$0.82
	Normalized FFO per share	$0.39				$0.38			$0.39				$1.52			$1.58

• The Company's 2024 guidance range includes activities outlined in the Components of Expected FFO on page 27 of the Supplemental Information.
• The Company's 2024 guidance range does not include any assumptions for recently announced or prospective JV seed portfolios, dispositions or share repurchases. These transactions will be incorporated into the Company's guidance expectations after completion.
• The Company's earnings per share and NAREIT FFO per share guidance ranges have been updated to reflect the impact of non-cash goodwill and real estate impairments recognized in 1Q 2024, as applicable.
  

The 2024 annual guidance range reflects the Company's view of current and future market conditions, including assumptions with respect to rental rates, occupancy levels, interest rates, and operating and general and administrative expenses. The Company's guidance does not contemplate impacts from gains or losses from dispositions, potential impairments, or debt extinguishment costs, if any. There can be no assurance that the Company's actual results will not be materially higher or lower than these expectations. If actual results vary from these assumptions, the Company's expectations may change.

EARNINGS CALL

• On Tuesday, May 7, 2024, at 12:00 p.m. Eastern Time, Healthcare Realty Trust has scheduled a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends.
• Simultaneously, a webcast of the conference call will be available to interested parties at https://investors.healthcarerealty.com/corporate-profile/webcasts under the Investor Relations section. A webcast replay will be available following the call at the same address.
• Live Conference Call Access Details:
  • Domestic Toll-Free Number: +1 833-470-1428 access code 240790;
  • All Other Locations: +1 404-975-4839 access code 240790.
• Replay Information:
  • Domestic Toll-Free Number: +1 866-813-9403 access code 656103;
  • All Other Locations: +1 929-458-6194 access code 656103.

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes nearly 700 properties totaling over 40 million square feet concentrated in 15 growth markets.

Additional information regarding the Company, including this quarter's operations, can be found at www.healthcarerealty.com. In addition to the historical information contained within, this press release contains certain forward-looking statements with respect to the Company. Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management’s intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, without limitation, the following: the Company's expected results may not be achieved; failure to realize the expected benefits of the Merger; significant transaction costs and/or unknown or inestimable liabilities; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company’s common stock could decline; general adverse economic and local real estate conditions; changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in the Company’s proposed market areas; changes in accounting principles generally accepted in the US; policies and guidelines applicable to REITs; the availability of properties to acquire; the availability of financing; pandemics and other health concerns, and the measures intended to prevent their spread, including the currently ongoing COVID-19 pandemic; and the potential material adverse effect these matters may have on the Company’s business, results of operations, cash flows and financial condition. Additional information concerning the Company and its business, including additional factors that could materially and adversely affect the Company’s financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in the Company’s 2023 Annual Report on Form 10-K and in its other filings with the SEC.

Consolidated Balance Sheets

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA

ASSETS
		1Q 2024			4Q 2023			3Q 2023			2Q 2023			1Q 2023
Real estate properties
Land	$	1,342,895		$	1,343,265		$	1,387,821		$	1,424,453		$	1,412,805
Buildings and improvements		10,902,835			10,881,373			11,004,195			11,188,821			11,196,297
Lease intangibles		816,303			836,302			890,273			922,029			929,008
Personal property		12,720			12,718			12,686			12,615			11,945
Investment in financing receivables, net		122,001			122,602			120,975			121,315			120,692
Financing lease right-of-use assets		81,805			82,209			82,613			83,016			83,420
Construction in progress		70,651			60,727			85,644			53,311			42,615
Land held for development		59,871			59,871			59,871			78,411			69,575
Total real estate investments		13,409,081			13,399,067			13,644,078			13,883,971			13,866,357
Less accumulated depreciation and amortization		(2,374,047	)		(2,226,853	)		(2,093,952	)		(1,983,944	)		(1,810,093	)
Total real estate investments, net		11,035,034			11,172,214			11,550,126			11,900,027			12,056,264
Cash and cash equivalents		26,172			25,699			24,668			35,904			49,941
Assets held for sale, net		30,968			8,834			57,638			151			3,579
Operating lease right-of-use assets		273,949			275,975			323,759			333,224			336,112
Investments in unconsolidated joint ventures		309,754			311,511			325,453			327,245			327,746
Other assets, net and goodwill		605,047			842,898			822,084			797,796			795,242
Total assets	$	12,280,924		$	12,637,131		$	13,103,728		$	13,394,347		$	13,568,884
LIABILITIES AND STOCKHOLDERS' EQUITY
		1Q 2024			4Q 2023			3Q 2023			2Q 2023			1Q 2023
Liabilities
Notes and bonds payable	$	5,108,279		$	4,994,859		$	5,227,413		$	5,340,272		$	5,361,699
Accounts payable and accrued liabilities		163,172			211,994			204,947			196,147			155,210
Liabilities of properties held for sale		700			295			3,814			222			277
Operating lease liabilities		229,223			229,714			273,319			278,479			279,637
Financing lease liabilities		74,769			74,503			74,087			73,629			73,193
Other liabilities		197,763			202,984			211,365			219,694			232,029
Total liabilities		5,773,906			5,714,349			5,994,945			6,108,443			6,102,045
Redeemable non-controlling interests		3,880			3,868			3,195			2,487			2,000
Stockholders' equity
Preferred stock, $0.01 par value; 200,000 shares authorized		—			—			—			—			—
Common stock, $0.01 par value; 1,000,000 shares authorized		3,815			3,810			3,809			3,808			3,808
Additional paid-in capital		9,609,530			9,602,592			9,597,629			9,595,033			9,591,194
Accumulated other comprehensive (loss) income		4,791			(10,741	)		17,079			9,328			(8,554	)
Cumulative net income attributable to common stockholders		717,958			1,028,794			1,069,327			1,137,171			1,219,930
Cumulative dividends		(3,920,199	)		(3,801,793	)		(3,684,144	)		(3,565,941	)		(3,447,750	)
Total stockholders' equity		6,415,895			6,822,662			7,003,700			7,179,399			7,358,628
Non-controlling interest		87,243			96,252			101,888			104,018			106,211
Total Equity		6,503,138			6,918,914			7,105,588			7,283,417			7,464,839
Total liabilities and stockholders' equity	$	12,280,924		$	12,637,131		$	13,103,728		$	13,394,347		$	13,568,884

Consolidated Statements of Income

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA

		1Q 2024			4Q 2023			3Q 2023			2Q 2023			1Q 2023
Revenues
Rental income	$	318,076		$	322,076		$	333,335		$	329,680		$	324,093
Interest income		4,538			4,422			4,264			4,233			4,214
Other operating		4,191			3,943			4,661			4,230			4,618
		326,805			330,441			342,260			338,143			332,925
Expenses
Property operating		121,078			121,362			131,639			125,395			122,040
General and administrative		14,787			14,609			13,396			15,464			14,935
Normalizing items 1		—			(1,445	)		—			(275	)		—
Normalized general and administrative		14,787			13,164			13,396			15,189			14,935
Transaction costs		395			301			769			669			287
Merger-related costs		—			1,414			7,450			(15,670	)		4,855
Depreciation and amortization		178,119			180,049			182,989			183,193			184,479
		314,379			317,735			336,243			309,051			326,596
Other income (expense)
Interest expense before merger-related fair value		(50,949	)		(52,387	)		(55,637	)		(54,780	)		(52,895	)
Merger-related fair value adjustment		(10,105	)		(10,800	)		(10,667	)		(10,554	)		(10,864	)
Interest expense		(61,054	)		(63,187	)		(66,304	)		(65,334	)		(63,759	)
Gain on sales of real estate properties		22			20,573			48,811			7,156			1,007
Gain (loss) on extinguishment of debt		—			—			62			—			—
Impairment of real estate assets and credit loss reserves		(15,937	)		(11,403	)		(56,873	)		(55,215	)		(31,422	)
Impairment of goodwill		(250,530	)		—			—			—			—
Equity (loss) gain from unconsolidated joint ventures		(422	)		(430	)		(456	)		(17	)		(780	)
Interest and other income (expense), net		275			65			139			592			547
		(327,646	)		(54,382	)		(74,621	)		(112,818	)		(94,407	)
Net (loss) income	$	(315,220	)	$	(41,676	)	$	(68,604	)	$	(83,726	)	$	(88,078	)
Net loss (income) attributable to non-controlling interests		4,384			1,143			760			967			953
Net (loss) income attributable to common stockholders	$	(310,836	)	$	(40,533	)	$	(67,844	)	$	(82,759	)	$	(87,125	)
Basic earnings per common share	$	(0.82	)	$	(0.11	)	$	(0.18	)	$	(0.22	)	$	(0.23	)
Diluted earnings per common share	$	(0.82	)	$	(0.11	)	$	(0.18	)	$	(0.22	)	$	(0.23	)
Weighted average common shares outstanding - basic		379,455			379,044			378,925			378,897			378,840
Weighted average common shares outstanding - diluted 2		379,455			379,044			378,925			378,897			378,840

1. 4Q 2023 normalizing items include severance costs and and 2Q 2023 includes non-routine legal costs..
2. Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount. As a result, the Company's OP totaling 3,681,225 units was not included.

Reconciliation of FFO, Normalized FFO and FAD 1,2,3

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA

		1Q 2024			4Q 2023			3Q 2023			2Q 2023			1Q 2023
Net (loss) income attributable to common stockholders	$	(310,836	)	$	(40,533	)	$	(67,844	)	$	(82,759	)	$	(87,125	)
Net loss attributable to common stockholders/diluted share 3	$	(0.82	)	$	(0.11	)	$	(0.18	)	$	(0.22	)	$	(0.23	)
Gain on sales of real estate assets		(22	)		(20,573	)		(48,811	)		(7,156	)		(1,007	)
Impairments of real estate assets		15,937			11,403			56,873			55,215			26,227
Real estate depreciation and amortization		181,161			182,272			185,143			185,003			186,109
Non-controlling loss from partnership units		(4,278	)		(491	)		(841	)		(1,027	)		(1,067	)
Unconsolidated JV depreciation and amortization		4,568			4,442			4,421			4,412			4,841
FFO adjustments	$	197,366		$	177,053		$	196,785		$	236,447		$	215,103
FFO adjustments per common share - diluted	$	0.51		$	0.46		$	0.51		$	0.62		$	0.56
FFO	$	(113,470	)	$	136,520		$	128,941		$	153,688		$	127,978
FFO per common share - diluted 4	$	(0.30	)	$	0.36		$	0.34		$	0.40		$	0.33
Transaction costs		395			301			769			669			287
Merger-related costs		—			1,414			7,450			(15,670	)		4,855
Lease intangible amortization		175			261			213			240			146
Non-routine legal costs/forfeited earnest money received		—			(100	)		—			275			—
Debt financing costs		—			—			(62	)		—			—
Severance costs		—			1,445			—			—			—
Impairment of goodwill		250,530			—			—			—			—
Allowance for credit losses 5		—			—			—			—			8,599
Merger-related fair value adjustment		10,105			10,800			10,667			10,554			10,864
Unconsolidated JV normalizing items 6		87			89			90			93			117
Normalized FFO adjustments	$	261,292		$	14,210		$	19,127		$	(3,839	)	$	24,868
Normalized FFO adjustments per common share - diluted	$	0.68		$	0.04		$	0.05		$	(0.01	)	$	0.06
Normalized FFO	$	147,822		$	150,730		$	148,068		$	149,849		$	152,846
Normalized FFO per common share - diluted	$	0.39		$	0.39		$	0.39		$	0.39		$	0.40
Non-real estate depreciation and amortization		485			685			475			802			604
Non-cash interest amortization, net 7		1,277			1,265			1,402			1,618			682
Rent reserves, net		(151	)		1,404			442			(54	)		1,371
Straight-line rent income, net		(7,633	)		(7,872	)		(8,470	)		(8,005	)		(8,246	)
Stock-based compensation		3,562			3,566			2,556			3,924			3,745
Unconsolidated JV non-cash items 8		(122	)		(206	)		(231	)		(316	)		(227	)
Normalized FFO adjusted for non-cash items		145,240			149,572			144,242			147,818			150,775
2nd generation TI		(20,204	)		(18,715	)		(21,248	)		(17,236	)		(8,882	)
Leasing commissions paid		(15,215	)		(14,978	)		(8,907	)		(5,493	)		(7,013	)
Capital expenditures		(5,363	)		(17,393	)		(14,354	)		(8,649	)		(8,946	)
Total maintenance capex		(40,782	)		(51,086	)		(44,509	)		(31,378	)		(24,841	)
FAD	$	104,458		$	98,486		$	99,733		$	116,440		$	125,934
Quarterly/annual dividends	$	119,541		$	118,897		$	119,456		$	119,444		$	119,442
FFO wtd avg common shares outstanding - diluted 9		383,413			383,326			383,428			383,409			383,335

1. Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by NAREIT. NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.”
2. FFO, Normalized FFO and Funds Available for Distribution ("FAD") do not represent cash generated from operating activities determined in accordance with GAAP and is not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered alternatives to net income attributable to common stockholders as indicators of the Company's operating performance or as alternatives to cash flow as measures of liquidity.
3. Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount.
4. For 1Q 2024, basic weighted average common shares outstanding was the denominator used in the per share calculation.
5. In 1Q 2023, allowance for credit losses included a $5.2 million credit allowance for a mezzanine loan and a $3.4 million reserve for three skilled nursing facilities.
6. Includes the Company's proportionate share of normalizing items related to unconsolidated joint ventures such as lease intangibles and acquisition and pursuit costs.
7. Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.
8. Includes the Company's proportionate share of straight-line rent, net and rent reserves, net related to unconsolidated joint ventures.
9. The Company utilizes the treasury stock method, which includes the dilutive effect of nonvested share-based awards outstanding of 254,261 for the three months ended March 31, 2024. Also includes the diluted impact of 3,681,225 OP units outstanding.
   

Reconciliation of Non-GAAP Measures

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA - UNAUDITED

Management considers funds from operations ("FFO"), FFO per share, normalized FFO, normalized FFO per share, funds available for distribution ("FAD") to be useful non-GAAP measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors.

The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs.

FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.” The Company defines Normalized FFO as FFO excluding acquisition-related expenses, lease intangible amortization and other normalizing items that are unusual and infrequent in nature. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, deferred financing fees amortization, share-based compensation expense and rent reserves, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered an alternative to net income as an indicator of the Company’s operating performance or as an alternative to cash flow as a measure of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.

Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per share, and FAD provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per share and FAD can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs.

Merger Combined Cash NOI and Merger Combined Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Merger Combined Cash NOI as rental income and less property operating expenses. Merger Combined Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, lease termination fees, tenant improvement amortization and leasing commission amortization. Merger Combined Cash NOI is historical and not necessarily indicative of future results.

Merger Combined Same Store Cash NOI compares Merger Combined Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties.

The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction for such properties through the application of additional resources including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures.

Any recently acquired property will be included in the same store pool once the Company has owned the property for eight full quarters. Newly developed or redeveloped properties will be included in the same store pool eight full quarters after substantial completion.

Ron Hubbard
Vice President, Investor Relations
P: 615.269.8290

FAQ

What is Healthcare Realty Trust's stock symbol?

Healthcare Realty Trust's stock symbol is HR.

What was Healthcare Realty Trust's (loss) income for the first quarter of 2024?

Healthcare Realty Trust reported a (loss) income of $(310.8) million for the first quarter of 2024.

What was Healthcare Realty Trust's Normalized FFO per share for the first quarter of 2024?

Healthcare Realty Trust's Normalized FFO per share was $0.39 for the first quarter of 2024.

What was the total value of the JV announced by Healthcare Realty Trust with KKR?

Healthcare Realty Trust announced a $383 million JV with KKR.

How many shares did Healthcare Realty Trust repurchase in April 2024?

Healthcare Realty Trust repurchased 3.0 million shares totaling $41.7 million in April.